Customize your JAMA Network experience by selecting one or more topics from the list below.
In the Letter to the Editor entitled “Opioids vs Nonopioids for Chronic Back, Hip, or Knee Pain,” published in the August 7, 2018, issue of JAMA,1 conflict of interest disclosures were omitted. Dr Singh’s full disclosure should have read “Dr Singh reported receiving grant funding from Takeda and Savient and consulting fees from Savient, Takeda, Regeneron, Merz, Iroko, Bioiberica, Crealta/Horizon, Allergan, WebMD, UBM, Medscape, Fidia, and the American College of Rheumatology; serving as principal investigator for an investigator-initiated study funded by Horizon Pharma through a grant to DINORA, a 501(c)(3) entity; being a member of the executive committee of Outcome Measures in Rheumatology, a member of the American College of Rheumatology’s (ACR) annual meeting planning committee, the Veterans Affairs Rheumatology field advisory committee, chair of the ACR Meet the Professor Workshop and Study Group subcommittee, and editor and director of the University of Alabama at Birmingham Cochrane Musculoskeletal Group Satellite Center on network meta-analysis.” This article was corrected online.
Omission of Conflicts of Interest. JAMA. 2018;320(12):1288. doi:10.1001/jama.2018.13704
Coronavirus Resource Center
Create a personal account or sign in to: